Different forms of LDL particles including reconstituted LDL, synthetic nano-LDL have been proposed as versatile nanocarriers or nanoplatforms for targeted delivery of drugs, photodynamic therapy agents and diagnostics or imaging agents to LDLR-positive tissues and cancer cells [32]. The gene discussed is LDLR; the disease is cancer.